Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration

Journal of Neurochemistry

Volumn 78, Issue 6, 2001, Pages 1415-1427

  Hansen, Henrik H ^a,d   Schmid, Patricia C ^b   Bittigau, Petra ^c   Lastres Becker, Isabel ^a   Berrendero, Fernando ^a   Manzanares, Jorge ^a   Ikonomidou, Chrysanthy ^c   Schmid, Harald H O ^b   Javier Fernandez Ruiz J ^a   Hansen, Harald S ^d  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF MINNESOTA   (United States)

^c HUMBOLDT UNIVERSITY   (Germany)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

2 arachidonoylglycerol; Anandamide; CB1 receptorexcitotoxicity, Neurodegeneration; NMDA

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CANNABINOID RECEPTOR; ETHANOLAMINE DERIVATIVE; GLUTAMIC ACID; MESSENGER RNA; MONOACYLGLYCEROL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GAS CHROMATOGRAPHY; HOMEOSTASIS; MALE; MASS SPECTROMETRY; NERVE CELL CULTURE; NERVE DEGENERATION; NEUROPROTECTION; NEUROTRANSMISSION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR DENSITY; RECEPTOR UPREGULATION; TOXICITY;

ANIMALS; ARACHIDONIC ACIDS; BRAIN CONCUSSION; CEREBRAL CORTEX; CORPUS STRIATUM; CRANIOCEREBRAL TRAUMA; DIZOCILPINE MALEATE; ENDOCANNABINOIDS; ETHANOLAMINES; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GLYCERIDES; MALE; N-METHYLASPARTATE; NERVE DEGENERATION; POLYUNSATURATED ALKAMIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RNA, MESSENGER;

ANIMALIA;

EID: 0034801539     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00542.x     Document Type: Article

References (51)

1. Bradykinin stimulates arachidonic acid release through the sequential actions of an sn-1 diacylglycerol lipase and a monoacylglycerol lipase
2. Stimulation of cannabinoid receptor agonist 2-arachidonoylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons
3. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period
4. Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells
5. Apoptotic neurodegeneration following trauma is markedly enhanced in the immature brain
6. Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP
7. Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain
8. Expression of the neuron-specific enolase gene by rat oligodendroglial cells during their differentiation
9. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
10. Biosynthesis and inactivation of endocannabinoids: Relevance to their proposed role as neuromodulators
11. The role of excitotoxicity in neurodegenerative disease: Implications for therapy
12. Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat
13. Postnatal developmental changes in NSE and NNE mRNA expression in the rat pineal gland: In situ hybridization histochemistry
14. A simple method for the isolation and purification of total lipids from animal tissues
15. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum
16. Accumulation of the anandamide precursor and other N-acylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal cell death
17. Characterization of glutamate-induced formation of N-acylphosphatidylethanolamine and N-acylethanolamine in cultured neocortical neurons
18. Formation of N-acyl-phosphatidylethanolamine and N-acylethanolamine (including anandamide) during glutamate-induced neurotoxicity
19. N-acylethanolamines and precursors - Relation to cell injury
20. Excitotoxic brain injury suppresses striatal high-affinity glutamate uptake in perinatal rats
21. Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methyl-aspartate neurotoxicity
22. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain
23. Neuron-specific enolase (NSE) and non-neuronal enolase (NNE) mRNAs are co-expressed in neurons of the rat cerebellum: In situ hybridization histochemistry
24. The palmitoylethanolamide and oleamide enigmas: Are these two fatty acid amides cannabimimetic?
25. NMDA and kainate induce inter-nucleosomal DNA cleavage associated with both apoptotic and necrotic cell death in the neonatal rat brain
26. From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: The ongoing story of cannabis
27. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
28. 31P NMR and enzyme activity study
29. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures
30. N-Acylethanolamine phospholipid metabolism in normal and ischemic rat brain
31. The endocannabinoid system as a target for therapeutic drugs
32. N-Methyl-D-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain
33. Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens
34. Metabolism of N-acylethanolamine phospholipids by mammalian phosphodiesterase of the phospholipase D type
35. Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain
36. Anandamide and other N-acylethanolamines in mouse peritoneal macrophages
37. N-Acylated glycerolipids and their derivatives
38. The N-acylation-phosphodiesterase pathway and cell signalling
39. A sensitive endocannabinoid assay. The simultaneous analysis of N-acylethanolamines and 2-monoacylglycerols
40. Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity
41. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures
42. Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats
43. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons
44. A second endogenous cannabinoid that modulates long-term potentiation
45. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain
46. Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor - Structure-activity relationship of 2-arachidonoylglycerol ether-linked analogues, and related compounds
47. Transacylasemediated and phosphodiesterase-mediated synthesis of N- arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes - Comparison with synthesis from free arachidonic acid and ethanolamine
48. Rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain after decapitation
49. Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata
50. Neurotoxicity and protection by cannabinoids